PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2019.7212020523747-763T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor ImmunitySang-Eun Lee, A-Ri Shin, Hyun-Jung Sohn, Hyun-Il Cho, Tai-Gyu Kimhttp://e-crt.org/upload/pdf/crt-2019-721.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2019.721, http://e-crt.org/upload/pdf/crt-2019-721.pdf
Vaccine10.1016/j.vaccine.2009.11.07120102861468-1476Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunityJennifer A. McWilliams, Phillip J. Sanchez, Catherine Haluszczak, Laurent Gapin, Ross M. Kedlhttps://api.elsevier.com/content/article/PII:S0264410X09018763?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X09018763?httpAccept=text/plain
The Vaccine Book10.1016/b978-0-12-802174-3.00030-82016581-596Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and ImmunityCarl H. Junehttps://api.elsevier.com/content/article/PII:B9780128021743000308?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128021743000308?httpAccept=text/plain
Vaccine10.1016/s0264-410x(00)00061-x200018252886-2894Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7Tae S. Kim, Su W. Chung, Seung Y. Hwanghttps://api.elsevier.com/content/article/PII:S0264410X0000061X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X0000061X?httpAccept=text/plain
Cancer Biotherapy and Radiopharmaceuticals10.1089/10849780414249902004193322-330Engineered Fusion Hybrid Vaccine of IL-18 Gene-Modified Tumor Cells and Dendritic Cells Induces Enhanced Antitumor ImmunityDajing Xia, Fang Li, Jim Xianghttp://www.liebertpub.com/doi/pdf/10.1089/1084978041424990
Molecular Therapy10.1016/s1525-0016(16)40124-3200816S269721. Enhanced Antitumor Cellular Immunity Induced by a Novel HPV-16 DNA Vaccine Encoding a E6/E7 Fusion Consensus Proteinhttps://api.elsevier.com/content/article/PII:S1525001616401243?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S1525001616401243?httpAccept=text/xml
Vaccine10.1016/j.vaccine.2013.10.058201432252940-2941Comment on “Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3−CD70−CD27+IgM+CD43+CD5+/−”Bert Verbinnen, Kris Covens, Xavier Bossuythttps://api.elsevier.com/content/article/PII:S0264410X13014369?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0264410X13014369?httpAccept=text/xml
Cancer Immunology, Immunotherapy10.1007/s0026200503181996433165-173Gene-modified tumor cells as cellular vaccineSivasubramanian Baskarhttp://link.springer.com/content/pdf/10.1007/s002620050318.pdf, http://link.springer.com/article/10.1007/s002620050318/fulltext.html, http://link.springer.com/content/pdf/10.1007/s002620050318
Cancer Immunology Immunotherapy10.1007/bf001991811982123Identification of effector T cells responsible for enhanced antitumor immunity induced by tumor vaccine and pyran copolymerTateshi Kataoka, Fujiko Oh-hashi, Yoshio Sakuraihttp://link.springer.com/content/pdf/10.1007/BF00199181.pdf, http://link.springer.com/article/10.1007/BF00199181/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF00199181
Molecular Therapy10.1016/s1525-0016(16)34767-0201321S166432. A Novel Cancer Cell Vaccine Using Induced Pluripotent Stem Cells Genetically Engineered To Produce GM-CSF Elicits Substantial Antitumor Immunity in a Syngeneic Mouse Modelhttps://api.elsevier.com/content/article/PII:S1525001616347670?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525001616347670?httpAccept=text/plain